Stay updated on FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial
Sign up to get notified when there's something new on the FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial page.

Latest updates to the FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial page
- Check5 days agoChange DetectedThe page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and includes a new section on HHS Vulnerability Disclosure.SummaryDifference0.3%
- Check12 days agoChange DetectedThe web page has been updated to include new content on 'Antibodies, Monoclonal', 'Physiological Effects of Drugs', and 'Immunologic Factors', while the revision number has been updated from v2.16.5 to v2.16.6.SummaryDifference0.7%
- Check19 days agoChange DetectedThe web page now includes a service alert about planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours. Additionally, the version has been updated from v2.16.4 to v2.16.5.SummaryDifference4%
- Check33 days agoNo Change Detected
- Check40 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference2%
- Check47 days agoChange DetectedThe web page has been updated from version 2.16.2 to version 2.16.3.SummaryDifference0.1%
- Check55 days agoChange DetectedThe web page has undergone a version update from v2.16.1 to v2.16.2, with several key topics related to antibodies, physiological effects of drugs, and immunologic factors removed.SummaryDifference0.7%
Stay in the know with updates to FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FG-3019 Safety in Idiopathic Pulmonary Fibrosis Clinical Trial page.